Cargando…

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations

This study is to investigate if any relationship exists between the telomerase reverse transcriptase (TERT) promoter or proto-oncogene BRAF mutation and ultrasound (US) and clinicopathological features of papillary thyroid carcinomas (PTCs). The study included 150 patients with surgically confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hahn, Soo Yeon, Kim, Tae Hyuk, Ki, Chang Seok, Kim, Sun Wook, Ahn, Soohyun, Shin, Jung Hee, Chung, Jae Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752494/ https://www.ncbi.nlm.nih.gov/pubmed/29312581 http://dx.doi.org/10.18632/oncotarget.22430

Ejemplares similares

BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association Study
por: Bertol, Bruna C., et al.
Publicado: (2023)

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
por: Yang, Li-Bo, et al.
Publicado: (2015)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
por: Huang, Meiling, et al.
Publicado: (2019)

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
por: Kim, Min Jhi, et al.
Publicado: (2022)

Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2018)

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
por: Kim, Sue Youn, et al.
Publicado: (2020)

Associations of the BRAF(V600E) Mutation with Sonographic Features and Clinicopathologic Characteristics in a Large Population with Conventional Papillary Thyroid Carcinoma
por: Park, Ah Young, et al.
Publicado: (2014)

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors
por: Choi, Sun Yi, et al.
Publicado: (2013)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
por: Lim, Jinsun, et al.
Publicado: (2023)

Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients
por: Sun, Yun, et al.
Publicado: (2013)

Association between BRAF(V600E) mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
por: Lu, Hai-Zhen, et al.
Publicado: (2017)

Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
por: Park, Jun, et al.
Publicado: (2021)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis
por: Liu, Chunping, et al.
Publicado: (2016)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
por: Li, Qian, et al.
Publicado: (2017)

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
por: Park, Jun, et al.
Publicado: (2021)

Preoperative detection of TERT promoter and BRAF(V600E) mutations in papillary thyroid carcinoma in high-risk thyroid nodules
por: Giorgenon, Tatiana Marina Vieira, et al.
Publicado: (2019)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas
por: Ylli, Dorina, et al.
Publicado: (2019)

LBODP092 Proposal Of Indication For Completion Thyroidectomy In Follicular Thyroid Carcinoma Using TERT Promoter Mutational Status
por: Park, Hyunju, et al.
Publicado: (2022)

Association analysis and the clinical significance of BRAF gene mutations and ultrasound features in papillary thyroid carcinoma
por: Liu, Ying, et al.
Publicado: (2019)

Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma
por: Cho, Seomin, et al.
Publicado: (2023)

Clinicopathological Features of Rare BRAF Mutations in Korean Thyroid Cancer Patients
por: Cho, Uiju, et al.
Publicado: (2014)

Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
por: Heo, Jung, et al.
Publicado: (2023)

What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?
por: Kim, Haejung, et al.
Publicado: (2022)

Clinicopathological features of recurrent papillary thyroid cancer
por: Zhu, Jian, et al.
Publicado: (2015)

Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status
por: Park, Hyunju, et al.
Publicado: (2023)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes
por: Baek, Hye Jin, et al.
Publicado: (2018)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Impact of Clinicopathologic Factors on Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
por: Kim, Bo-Yeon, et al.
Publicado: (2012)

The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer
por: Zarkesh, Maryam, et al.
Publicado: (2018)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
por: Lee, Doh Young, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d2f1mk3ej0979apaa7cqq15rnj